Skip to main content

Is Dsuvia (sufentanil) a controlled substance?

Medically reviewed by Drugs.com. Last updated on Nov 21, 2023.

Official answer

by Drugs.com

Yes. Dsuvia (sufentanil) is a strong pain medication known as an opioid and is classified as a controlled substance.

Sufentanil, the active medication in Dsuvia, is a Schedule II controlled substance under the US Controlled Substances Act.

  • Drugs listed in Schedule II have a high potential for abuse, but also have a currently accepted and legal medical use.
  • Abuse of drugs in Schedule II may lead to severe psychological or physical dependence.
  • As an opioid, Dsuvia exposes users to the risks of addiction, abuse, and misuse, which can lead to overdose and death, even when taken as recommended by a health care provider.
  • Other pain medications also listed in Schedule II include morphine and oxycodone.

Read next

Ibuprofen is short acting, while naproxen is long acting and more likely to cause an upset stomach. Naproxen and ibuprofen are both NSAIDs so they are similar in many ways, but there are important differences. Continue reading

Gabapentin can help relieve nerve pain in some people with postherpetic neuralgia (nerve pain after shingles) and peripheral diabetic neuropathy (nerve pain in the feet in people with diabetes). A Cochrane review reported that 3 to 4 patients out of every 10 with either of these conditions experienced at least a 50% reduction in pain intensity when prescribed gabapentin at dosages of 1800mg-3600 mg/day (gabapentin encarbil: 1200mg-3600 mg/day). This compared with only 1 or 2 out of every 10 given a placebo (an inactive treatment). People who had an improvement in pain relief with gabapentin are also expected to experience an improvement in sleep, fatigue, and in their mood. Continue reading

Even though aspirin and Ibuprofen are both NSAIDs (nonsteroidal anti-inflammatory drugs) and work similarly, there are several differences between the two drugs and they are not considered interchangeable. Continue reading

Related medical questions

Drug information

Related support groups

Medical Disclaimer